Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
5226
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $134K | ﹤0.01% |
443
-3,350
| -88% | -$1.01M |
|
|
AVLR
5227
DELISTED
Avalara, Inc.
AVLR
| $134K | ﹤0.01% |
3,820
+3,120
| +446% | +$129K |
|
|
MRT
5228
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $133K | ﹤0.01% |
13,738
+6,642
| +94% | +$70.4K |
|
|
AMNB
5229
DELISTED
American National Bankshares Inc
AMNB
| $133K | ﹤0.01% |
3,390
+2,786
| +461% | +$113K |
|
5230
Miller Industries
MLR
$620M
| $132K | ﹤0.01% |
4,941
+3,767
| +321% | +$101K |
|
5231
PUT
Packaging Corp of America
PKG
$22.9B
| $132K | ﹤0.01% |
1,200
-800
| -40% | -$90.2K |
|
5232
Simulations Plus
SLP
$370M
| $132K | ﹤0.01% |
6,518
+5,650
| +651% | +$110K |
|
5233
A10 Networks
ATEN
$1.97B
| $131K | ﹤0.01% |
21,608
+17,899
| +483% | +$121K |
|
5234
Biglari Holdings Class B
BH
$1.2B
| $131K | ﹤0.01% |
725
+174
| +32% | +$33.3K |
|
|
CHMI
5235
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $131K | ﹤0.01% |
7,251
+3,201
| +79% | +$58.7K |
|
5236
Nathan's Famous
NATH
$399M
| $131K | ﹤0.01% |
1,594
+1,384
| +659% | +$127K |
|
5237
Arbutus Biopharma
ABUS
$923M
| $130K | ﹤0.01% |
13,769
+11,177
| +431% | +$111K |
|
5238
Anterix
ATEX
$1.81B
| $130K | ﹤0.01% |
3,819
+2,882
| +308% | +$84.3K |
|
5239
Costamare
CMRE
$1.69B
| $130K | ﹤0.01% |
19,904
-8,085
| -29% | -$57.7K |
|
5240
CALL
iShares MSCI Canada ETF
EWC
$6.48B
| $130K | ﹤0.01% |
4,500
| – | – |
|
5241
Primis Financial Corp
FRST
$405M
| $130K | ﹤0.01% |
7,968
+6,404
| +409% | +$111K |
|
|
MSB
5242
Mesabi Trust
MSB
$309M
| $130K | ﹤0.01% |
+4,916
| New | +$134K |
|
|
VRE
5243
CALL
DELISTED
Veris Residential
VRE
| $130K | ﹤0.01% |
+6,100
| New | +$124K |
|
5244
VSE Corp
VSEC
$6.79B
| $130K | ﹤0.01% |
3,917
+1,928
| +97% | +$78.9K |
|
|
LGTY
5245
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $130K | ﹤0.01% |
10,717
+7,897
| +280% | +$119K |
|
|
CDMO
5246
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $130K | ﹤0.01% |
18,997
+15,277
| +411% | +$90.6K |
|
|
GPOR
5247
CALL
DELISTED
Gulfport Energy Corp.
GPOR
| $130K | ﹤0.01% |
12,500
-32,000
| -72% | -$367K |
|
|
FTSV
5248
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $130K | ﹤0.01% |
+8,710
| New | +$130K |
|
5249
CALL
Clean Harbors
CLH
$16.4B
| $129K | ﹤0.01% |
+1,800
| New | +$114K |
|
5250
Citizens & Northern Corp
CZNC
$459M
| $129K | ﹤0.01% |
4,926
+3,414
| +226% | +$93.4K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.